Literature DB >> 163594

Nuclear bodies produced in astrocytes by tilorone.

S Levine, R Sowinski, E M Hoenig.   

Abstract

Large, eosinophilic, nonglycogenic nuclear inclusions were produced in the central nervous system by the drug tilorone. At the light microscope level, the inclusions occurred predominantly in astrocytes. Ultrastructurally, they were identical to the nuclear bodies described in many cell types under many conditions. The bodies were produced by tilorone in small numbers in the median eminence, a part of the hypothalamus that lacks a blood-brain barrier. They were produced in only 2 or 3 days in large numbers adjacent to zones of thermal or traumatic necrosis or in areas of inflammation. These facts, and the distribution of affected astrocytes, indicated that permeability factors and cerebrospinal fluid flow were involved in the development of the nuclear bodies. The large size and large number of nuclear bodies produced by tilorone should facilitate studies of this poorly understood nuclear organelle.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 163594      PMCID: PMC1912468     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Selective depletion of thymus dependent areas in lymphoid tissue by tilorone.

Authors:  S Levine; J P Gibson; H Megel
Journal:  Proc Soc Exp Biol Med       Date:  1974-05

2.  An ultrastructural study of spheroidal nuclear bodies found in gliomas.

Authors:  J J Vázquez; G Ortuño; J Cervós-Navarro
Journal:  Virchows Arch B Cell Pathol       Date:  1970

Review 3.  Hyperacute, neutrophilic, and localized forms of experimental allergic encephalomyelitis: a review.

Authors:  S Levine
Journal:  Acta Neuropathol       Date:  1974       Impact factor: 17.088

4.  Light and electron microscopy observations on the development of viral particles in the inclusions of Dawson's encephalitis (subacute sclerosing panencephalitis).

Authors:  R M Herndon; L J Rubinstein
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

5.  Nuclear bodies in reactive astrocytes in two cases of leukodystrophy in monozygotic twins.

Authors:  V Predescu; M Alexianu; D Christodorescu; C Oancea; A Petrovici
Journal:  Acta Neuropathol       Date:  1973       Impact factor: 17.088

6.  Large granular nuclear bodies (karyosphaeridia) in experimental Borna virus infection.

Authors:  K Blinzinger; A P Anzil
Journal:  J Comp Pathol       Date:  1973-10       Impact factor: 1.311

7.  Subacute sclerosing panencephalitis. Ultrastructural study of a brain biopsy.

Authors:  G M Zu Rhein; S M Chou
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

8.  The fine structure of nuclear inclusions in the brain of experimental golden hamsters.

Authors:  N Popoff; S Stewart
Journal:  J Ultrastruct Res       Date:  1968-06

9.  Carbonyl iron: a new adjuvant for experimental autoimmune diseases.

Authors:  S Levine; R Sowinski
Journal:  J Immunol       Date:  1970-12       Impact factor: 5.422

10.  Nuclear changes in glial cells after aluminum hydroxide.

Authors:  R F de Estable-Puig; J F de Estable-Puig; C Romero
Journal:  Virchows Arch B Cell Pathol       Date:  1971
View more
  4 in total

1.  Intranuclear inclusions in pericytes of the hypothalamus of the rat.

Authors:  M Lafarga; J P Hervás
Journal:  Cell Tissue Res       Date:  1978-10-17       Impact factor: 5.249

2.  Intranuclear inclusion bodies within neurons of spinal and cranial ganglia in three cyprinid species.

Authors:  K L Hoover; J C Harshbarger; C W Lee; W Banfield; S C Chang
Journal:  Cell Tissue Res       Date:  1981       Impact factor: 5.249

3.  Necrotic myelopathy (myelomalacia) in rats with allergic encephalomyelitis treated with tilorone.

Authors:  S Levine; R Sowinski
Journal:  Am J Pathol       Date:  1976-02       Impact factor: 4.307

4.  Depletion of lymphoid tissues by tilorone. Ultrastructure and synergistic interaction with antilymphocyte serum.

Authors:  S Levine; P Cacho; R Sowinski; W L Thelmo
Journal:  Am J Pathol       Date:  1983-05       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.